ADVERTISEMENT



Google       

Home -> Law Blog Directory -> Legal News Blogs -> FindLaw's Common Law

OR PHONE (866) 635-1838 for Bankruptcy Help, (866) 635-6190 for Divorce,
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense

Find a Local Lawyer

Bankruptcy (866) 635-1838
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402

Bookmark

Legal News

: FindLaw's Common Law

FDA Rejects Yet Another Diet Drug: Qnexa

ADVERTISEMENTS

Another diet pill lost its battle for approval with the Food and Drug Administration this week. The FDA denied approval for the diet drug Qnexa, developed by Vivus, located in Mountain View, California. Overall, this is the third diet drug to receive a major setback from the FDA. Last week, the agency rejected the drug Lorcaserin for causing tumors in lab rats. As noted in a prior post, earlier in October, the drug Meridia was taken off the market.

A statement on the Vivus website says the FDA is seeking more safety information from the company about Qnexa, reports The New York Times. According to the company, the FDA wants more data on the drug's possible links to birth defects and heart problems. Vivus says it can provide the FDA with the necessary information in about six weeks.

A high incidence of heart risks also caused the FDA to force Meridia off the market. Back in 1997, the popular diet drug combo fen-phen was also pulled from the market after it was found to damage heart valves.

Unfortunately for those struggling with obesity, it is a common cause of heart trouble as well. As The Times reminds us, one third of Americans are described as obese. Obesity can lead to health issues such as cancer and diabetes, as well as heart risks.

The FDA is struggling to balance the risk of these diet drugs with their efficacy. A high heart risk is not worth the relatively minor weight loss that some of these drugs provide. However, this puts the agency in a quandary according to Morgan Downey, an advocate for obese people who also consults for pharmaceutical companies. ?The FDA has gotten itself into a real knot,? Downey told The Times. ?They can?t approve a very effective drug and they can?t approve a modest drug.?

According to The Times, there has been no new prescription diet pill approved since Roche?s Xenical in 1999. Xenical is currently the only drug approved for long-term use in managing weight.

Related Resources:


Full post as published by FindLaw's Common Law on October 29, 2010 (boomark / email).

Bloggers, promote your law blog by nominating your blog for inclusion in USLaw.com's Law Blog Directory and RSS Reader. Benefits described.
Related Law Articles

Lawsuits and Settlements

Related Searches

























































































































US Law
#1 Online Legal Resource













Your Blog Subscriptions
Subscribe to blogs

10,000+ Law Job Listings
Lawyer . Police . Paralegal . Etc
Earn a law-related degree
Are you the author of this blog? Adding USLaw.com to your Blogroll increases relevance. You qualify to display a USLaw Network badge.
Suggest changes to this blog's description or nominate another for inclusion. Register for updates.


Practice Area
Zip Code:

Contact a Lawyer Now!






0.0133 secs (new cache)